Sebastian Andres Cruz-Saavedra, MD
Dermatology · Bellflower
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 1 carrier
- Offices
- 8
Offices
8 locations · Southern California Permanente Medical Group · Sutter Bay Medical Foundation
Plans that list them
13 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cruz-Saavedra’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A185384 · Current
Licensed to practise in California · since 2023 · expires 2027-04-30 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$6,005
Medicare paid this office $6,005 for 25 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 13 | $2,066 | $159 |
Procedures Medicare counted
| Removal of skin lesions | 31 | More than 69% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
25 Original Medicare patients in 2024. Average age 74 · Women 48% · Health risk score 0.73. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 48%.
The office billed $21,602, Medicare allowed $7,524 and paid $6,005; for 64 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$18,371
Pharmacies billed $18,371 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 292) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
274 generic and 18 brand-name prescriptions · $18,371 in drug cost · 15 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tacrolimus | 20 | $2,602 | $130 |
| Clobetasol Propionate | 40 | $1,416 | $35 |
| Ketoconazole | 49 | $748 | $15 |
| Triamcinolone Acetonide | 30 | $741 | $25 |
| Fluocinonide | 17 | $342 | $20 |
See all 8 drugs
| Tacrolimus | 20 | $2,602 | $130 |
| Clobetasol Propionate | 40 | $1,416 | $35 |
| Ketoconazole | 49 | $748 | $15 |
| Triamcinolone Acetonide | 30 | $741 | $25 |
| Fluocinonide | 17 | $342 | $20 |
| Doxycycline Monohydrate | 11 | $285 | $26 |
| Hydrocortisone | 20 | $256 | $13 |
| Mupirocin | 15 | $132 | $9 |
Year by year
| 2024 | 292 | 105 | 0% (0) | 6% | $18,371 |
| 2023 | 212 | 68 | 0% (0) | 6% | $19,929 |
| 2022 | 117 | 34 | 0% (0) | 22% | $32,201 |
| 2021 | 95 | 40 | None | 22% | $13,858 |
| 2020 | 63 | 22 | None | 19% | $3,733 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Tacrolimus | 13 | $2,040 | $157 |
| Clobetasol Propionate | 26 | $1,710 | $66 |
| Ketoconazole | 17 | $579 | $34 |
| Triamcinolone Acetonide | 20 | $375 | $19 |
| Hydrocortisone | 15 | $108 | $7 |
| Mupirocin | 11 | $91 | $8 |
2022: 2 drugs
| Ketoconazole | 12 | $280 | $23 |
| Hydrocortisone | 12 | $66 | $5 |
Money from drug and device companies
$30 in 2025
| 2025 | 1 | 1 | None | $30 |
| 2024 | 5 | 6 | None | $708 |
| 2023 | 8 | 20 | None | $1,821 |
| 2022 | 7 | 10 | None | $1,168 |
| 2021 | 4 | 4 | None | $441 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $30 | 1 payment
|
See the published payment
| Janssen Biotech | Meals · 2025-02-26 | Tremfya | $30 |
See earlier years (2024, 2023, 2022, 2021)
2024: $708
| Dermavant Sciences | Vtama | $321 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | None | $125 | 1 payment
|
| Genzyme | Dupixent | $122 | 1 payment
|
| Abbvie | None | $115 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $25 | 1 payment
|
2023: $1,821
| Dermavant Sciences | Vtama | $453 | 4 payments
|
| Ucb | Bimzelx | $446 | 4 payments
|
| Genzyme | Dupixent | $291 | 3 payments
|
| Janssen Biotech | Tremfya | $236 | 2 payments
|
| AbbVie | Rinvoq | $211 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | None | $125 | 1 payment
|
| Galderma Laboratories L.P. | None | $39 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $22 | 1 payment
|
2022: $1,168
| Abbvie | Rinvoq | $331 | 3 payments
|
| Ucb | None | $268 | 2 payments
|
| Janssen Scientific Affairs | Tremfya | $145 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $125 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | None | $125 | 1 payment
|
| Amgen | None | $120 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $55 | 1 payment
|
2021: $441
| Stemline Therapeutics | None | $130 | 1 payment
|
| Genzyme | Libtayo | $125 | 1 payment
|
| Janssen Scientific Affairs | Tremfya | $121 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $65 | 1 payment
|
Professional record
- NPI
- 1356962898
- Licence
- CA A185384, IL 125.076048California A185384: Current · expires 2027-04-30
- Trained
- University of Chicago, Pritzker School of Medicine, 2020
- Group
- Southern California Permanente Medical Group · Sutter Bay Medical Foundation
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Internal medicine (207R00000X)
- Mailing address
- 1441 Eastlake Ave, Ezralow Tower, Suite 5301, Los Angeles, CA, 90089
- NPI first listed
- 2020-05-06
- NPI last updated
- 2023-12-28
- NPI record certified
- 2023-12-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1441 Eastlake Ave, Los Angeles, CA, 90089
This office lists an electronic records connection.